LEO Pharma applies to EMA to expand Anzupgo use to adolescents
LEO Pharma has submitted an application to the European Medicines Agency (EMA) seeking to expand the label for Anzupgo (delgocitinib)…
News
SK Capital Partners supports Swixx BioPharma’s global expansion
J&J gains label expansion approval for Akeega in mCSPC
First gonorrhoea antibiotics in decades herald new era of treatment
Sanofi shares fall 6% after double setback for MS drug tolebrutinib
FDA approves Acadia’s Daybue Stix for Rett syndrome
Sobi buys Arthrosi to expand gout treatment pipeline
EU inches closer to new pharma legislation amid competitiveness drive
